Related Experiment Video

Updated: May 11, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
07:45

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

Circulating microRNAs as novel biomarkers for diabetes mellitus

Claudiane Guay1, Romano Regazzi

  • 1University of Lausanne, Department of Fundamental Neurosciences, Rue du Bugnon 9, 1005 Lausanne, Switzerland.

Nature Reviews. Endocrinology
|May 1, 2013
PubMed

Insights

Circulating microRNAs (miRNAs) show distinct blood level changes in both type 1 and type 2 diabetes, potentially years before diagnosis. These blood-based biomarkers may help predict diabetes complications, improving patient care.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Biology
  • Genetics and Genomics

Background:

  • Diabetes mellitus, encompassing type 1 and type 2, arises from insufficient insulin secretion or reduced insulin sensitivity, leading to impaired blood glucose homeostasis.
  • Diabetic complications significantly reduce patient quality of life and life expectancy, highlighting the need for early detection and risk assessment biomarkers.
  • MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are implicated in various physiological and pathophysiological processes.

Purpose of the Study:

  • To investigate the potential of circulating microRNAs (miRNAs) as biomarkers for early detection of diabetes mellitus (type 1 and type 2).
  • To explore the utility of circulating miRNAs in identifying individuals at risk of developing long-term diabetic complications.
  • To assess the diagnostic and prognostic value of blood-based miRNA profiles in diabetes management.

Main Methods:

  • Analysis of circulating microRNA (miRNA) profiles in blood samples from individuals with and without diabetes mellitus.
  • Comparison of miRNA expression patterns between type 1 and type 2 diabetes mellitus patients.
  • Correlation of specific circulating miRNA levels with the presence and severity of diabetic complications.

Main Results:

  • Distinct alterations in circulating microRNA (miRNA) profiles are associated with both type 1 and type 2 diabetes mellitus.
  • These characteristic miRNA changes can be detectable years prior to the clinical manifestation of diabetes.
  • Specific circulating miRNAs show predictive potential for the development of long-term diabetic complications.

Conclusions:

  • Circulating microRNAs (miRNAs) represent promising biomarkers for the early diagnosis of diabetes mellitus.
  • Blood-based miRNA analysis may facilitate the identification of individuals at high risk for developing diabetes-related complications.
  • Further research and overcoming technical challenges could establish circulating miRNAs as a valuable tool in the clinical diagnostic arsenal for diabetes.

More Related Videos

Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs10:28

Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs

Published on: April 14, 2015

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...